StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — Kunal Saraogi

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

byKunal SaraogiHorizon: NA (inferred 1 year)11 Sept 2026via Zee Business (Live)

Entry₹2,733.7Inferred
Target₹3,500
Total upside +28.03% (call closed)
Stop loss₹2,700-1.23% risk
Exit₹2,70015 Sept 2026, 12:09 pm
Stop-loss hit-1.23%
Follow Kunal Saraogi for new callsGet alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 245 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
4 supporting3 neutral0 opposing
Supports the BUY call (4)

Caplin Point's Unit Gets Colombia's INVIMA GMP Compliance Nod for Oncology Drugs

NewsGoogle News·5 Sept · 1w ago

(opens in new tab)

Caplin Point Subsidiary Gets Colombian GMP Certification

NewsGoogle News·1 Sept · 2w ago

(opens in new tab)

Caplin Steriles Gets 10 USFDA Observations at Gummidipoondi Facility

NewsGoogle News·22 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (3)

Caplin Point Labs schedules AGM with ₹8 per share dividend payout

NewsGoogle News·4 Sept · 1w ago

(opens in new tab)

Caplin Point Laboratories: AGM Details and ₹8 Dividend

NewsGoogle News·3 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from Kunal Saraogi

Every call and its outcome